Recruiting Neuroendocrine Tumors Studies in Omaha
About Neuroendocrine Tumors Clinical Trials in Omaha
Neuroendocrine tumors (NETs) develop from hormone-producing cells and can occur in many organs, most commonly the gastrointestinal tract and lungs. They range from slow-growing to aggressive. Treatment includes surgery, somatostatin analogs, targeted therapy, and peptide receptor radionuclide therapy.
There are currently 2 neuroendocrine tumors clinical trials recruiting participants in Omaha, NE. These studies are seeking a combined 2,000,138 participants. Research is being sponsored by Helix, Inc, Molecular Partners AG. Clinical trial participation is free and participants receive study-related medical care at no cost.
Neuroendocrine Tumors Clinical Trials in Omaha — FAQ
Are there neuroendocrine tumors clinical trials in Omaha?
Yes, there are 2 neuroendocrine tumors clinical trials currently recruiting in Omaha, NE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Omaha?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Omaha research site will contact you about next steps.
Are clinical trials in Omaha free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Omaha studies also compensate for your time and travel.
What neuroendocrine tumors treatments are being tested?
The 2 active trials in Omaha are testing new therapies including novel drugs, biologics, and treatment approaches for neuroendocrine tumors.
Data updated July 13, 2026 from ClinicalTrials.gov